Oxidative stress correction with metabolic preparations, new possibilities of antioxidant protection in primary glaucoma


  • I. N. Mikheytseva The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine
  • V. N. Yelskiy The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine




quercetin, melatonin, glaucoma, oxidative stress


There were studied antioxidant action of water-soluble form of quercetin – corvitin and melatonin in rabbits with glaucoma model. It was shown intravenous injections of corvitin essentially decreased oxidative stress in animals with advanced stage of experimental glaucoma. Prophylactic-protective apply of melatonin on the basis of model induction in significant degree protected oxidative stress development.


Краморенко Ю.С. Эмоксипин в лечении первичной глаукомы /Краморенко Ю.С., Добрица Т.А., Иманбаева З.А., Егоров Е.А. // Вестн. офтальмол. - 1992. - № 1. - С. 14-15. 17.

Михейцева И.Н. Оксидативный стресс и эндотелиальная дисфункция как патогенетические факторы в глаукомном процессе/Михейцева И.Н.// Патологія. – 2008. – т.5, №3. – С.125-126

Мойбенко А.А. Эффективность водорастворимой формы кверцетина (Корвитина) при лечении острого коронарногосиндрома с элевацией сегмента ST / Мойбенко А.А., Пархоменко А.Н., Кожухов С.Н.// Журн.АМН України – 2003. – Т.9, № 2. – С.361-370.

Мошетова Л.К. Лютеин-комплекс в лечении глаукомной оптической нейропатии/ Мошетова Л.К., Алексеев И.Б., Ивашина А.В.//Клиническая офтальмология – 2005. - т.6, № 2. - С. 67-69.

Патент України №61478 Спосіб моделювання адреналін-індукованої глаукоми у кролів/ Михейцева І.М. Опубл. 25.07.11, Бюл.№14.

Филина А.А. Антиоксидантная терапия первичной глаукомы/ Филина А.А.//Вестник офтальмол. – 1994. – т. 110, №1. – С. 33 — 35.

Ansari M.A. Protective effect of quercetin in primary neurons against Abeta (1-42): relevance to Alzheimer’s disease/ Ansari M.A., Abdul H.M., Joshi G. et al. // J. Nutr. Biochem. – 2009. – v.20, №4. – Р.269-275.

Bonnefont-Rousselot D. Melatonin: action as antioxidant and potential applications in human disease and aging/ Bonnefont-Rousselot D., Collin F.//Toxicology. – 2010. – v.278. – P.55-67.

Evans S.C. Ophthalmic nutrition and prevention of eye disorder and blindness/ Evans S.C. // Nutrition Metabolism - 1977. – v. 21. – P. 268-272.

Ferreira S.M. Oxidative stress markers in aqueous humor of glaucoma patients/ Ferreira S.M., Lerner S.F., Brunzini R. et al.//Am J Ophthalmol. – 2004. – v.137. - P.62–69.

Flammer J. Glaucomatous optic neuropathy: a reperfusion injury/ Flammer J //Klin Monatsbl Augenheilkd. – 2000. - v.218. P.290–291.

Flammer J. What is the present pathogenetic concept of glaucomatous optic neuropathy? /Flammer J., Mozaffarieh M.// Surv Ophthalmol. – 2007. - v.52. –P.162–173.

Gherghel D. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma/ Gherghel D., Griffiths H.R., Hilton E.J. et al.//Invest Ophthalmol Vis Sci. – 2005. – v.46. – P.877–883.

Harwood M. A critical review of the data related to the safety of qurcetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties/ Harwood M., Danielewska-Nikiel B., Borzelleca J.F. et al. // Food Chem Toxicol. - 2007. – v.45. – P.2179-2205.

Izzotti A. The role of oxidative stress in glaucoma/ Izzotti A., Bagnis A., Sacca S.C. //Mutat Res. – 2006. - v.612. - P.105–14.

Krishna S.M. Vitamin A and primary glaucoma/ Krishna S.M., Shukla P.K. // J. Glaucoma – 1982. – v. 4. – P. 226-227.

Mozaffarieh M. Oxygen and blood flow: players in the pathogenesis of glaucoma/Mozaffarieh M., Grieshaber M., Flammer J.// Mol Vis. – 2008. – v.14. – P. 224–233.

Reiter R.J. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging / R.J.Reiter, D.X.Tan, L.C.Manchester, M.R.El-Sawi // Ann. NY Acad. Sci. – 2002. – Vol. 959. – P. 238-250.

Reiter R.J. Melatonin: Lowering the High Price of Free radicals / Reiter R.J. // News Phisiol. Sci. –2000. –Vol. 15. –P. 246-250.

Ritch R. Potential role gingo biloba extract in the treatment of glaucoma/Rithc R.// Med Hypotheses - 2000. – v.54, №2. – Р.221- 235.

Sacca S.C. Glaucomatous outflow pathway and oxidative stress/ Sacca S.C., Izzotti A., Rossi P., Traverso C.// Exp Eye Res. – 2007. – v.84. - P.389–399.

Tezel G. Oxidative stress in glaucoma neurodegeneration: mechanism and consequences/ Tezel G. // Prog. Retin Eye Res. – 2006. – v.25, №5 – P.490-513.

Vauzour D. The neuroprotective potential of flavonoids: a multiplicity of effects/ Vauzour D., Vafeiadou K., Rodriguez-Mateos A. et al.// Genes Nutr. – 2008. - №3. – Р.115-126.






No Section